BRISTOL, Tenn.--(BUSINESS WIRE)--Aug. 9, 2006--King Pharmaceuticals, Inc. (NYSE:KG - News) announced today that total revenues increased 8% to $500 million during the second quarter ended June 30, 2006, compared to $463 million in the second quarter of 2005. Including special items, net earnings increased to $111 million and diluted earnings per share increased to $0.46 during the second quarter ended June 30, 2006, compared to net income of $20 million and diluted earnings per share of $0.08 in the same period of the prior year. Excluding special items, net earnings increased to $112 million and diluted earnings per share increased to $0.46 during the second quarter ended June 30, 2006, compared to net earnings of $107 million and diluted earnings per share of $0.44 in the second quarter of 2005.
